Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.16 USD | -0.47% | -8.42% | +21.00% |
05-13 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
05-08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.00% | 2.1B | |
-4.92% | 12.27B | |
-5.82% | 7.99B | |
+5.43% | 5.69B | |
+26.16% | 5.42B | |
-9.58% | 4.13B | |
-59.63% | 2.7B | |
+8.44% | 2.6B | |
-3.70% | 2.38B | |
+0.26% | 1.55B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Myriad Genetics Q1 Adjusted Loss Narrows, Revenue Declines; Reiterates 2022 Guidance